Literature DB >> 931792

Cefuroxime - a new cephalosporin antibiotic.

C H O'Callaghan, R B Sykes, D M Ryan, R D Foord, P W Muggleton.   

Abstract

Cefuroxime is a new broad spectrum cephalosporin antibiotic for administration by injection. It is stable to most beta-lactamases. It is active against gram-positive organisms, including penicillinase-producing staphylococci, and has wide activity against gram-negative bacilli including Enterobacter and many strains of indole-positive Proteus spp. The substance is also highly active against Haemophilus influenzae and Neisseria gonorrhoeae. Studies on human volunteers showed that it produced high, long-lasting blood levels with virtually complete recovery of unchanged antibiotic in the urine. No evidence of toxicity due to cefuroxime was found. Slight, short-lived pain followed intramuscular injection, and the compound was well tolerated intravenously.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 931792     DOI: 10.7164/antibiotics.29.29

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  34 in total

1.  Modification of the pharmacokinetics and dosage of cefuroxime by endotoxin-induced fever in buffalo calves.

Authors:  R K Chaudhary; A K Srivastava; S Rampal
Journal:  Vet Res Commun       Date:  1999-10       Impact factor: 2.459

2.  beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  The in vitro and in vivo Antibacterial Activity of Cefuroxime.

Authors:  S Goto
Journal:  Proc R Soc Med       Date:  1977

4.  A clinical and bacteriological study of cefuroxime.

Authors:  A C Scott
Journal:  Proc R Soc Med       Date:  1977

5.  Cefuroxime concentrations in serum, urine and bile: pharmacokinetic profile.

Authors:  J M Brogard; J Kopferschmitt; M Pinget; J P Arnaud; J Lavillaureix
Journal:  Proc R Soc Med       Date:  1977

6.  Bioavailability of Cefuroxime in Various Sites including Bile, Sputum and Bone.

Authors:  G K Daikos; J Kosmidis; C Stathakis; A Anyfantis; T Plakoutsis; B Papathanassiou
Journal:  Proc R Soc Med       Date:  1977

7.  Cefuroxime in renal insufficiency: therapeutic results in various infections and pharmacokinetics including the effects of dialysis.

Authors:  J Kosmidis; C Stathakis; A Anyfantis; G K Daikos
Journal:  Proc R Soc Med       Date:  1977

8.  β-Lactamase Resistant Cephalosporins with Particular Reference to Cefuroxime.

Authors:  M H Richmond
Journal:  Proc R Soc Med       Date:  1977

9.  Biliary tract excretion of cefuroxime.

Authors:  J E Sales; D M Rimmer
Journal:  Proc R Soc Med       Date:  1977

10.  Human pharmacology of cefotaxime (HR 756), a new cephalosporin.

Authors:  R Lüthy; R Münch; J Blaser; H Bhend; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.